Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
NVIDIA
NVDA
|
$549M |
| 2 |
Chipotle Mexican Grill
CMG
|
$467M |
| 3 |
Boeing
BA
|
$441M |
| 4 |
Broadcom
AVGO
|
$350M |
| 5 |
CoStar Group
CSGP
|
$320M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$1.62B |
| 2 |
Progressive
PGR
|
$570M |
| 3 |
ASML
ASML
|
$562M |
| 4 |
Mastercard
MA
|
$313M |
| 5 |
Johnson & Johnson
JNJ
|
$300M |
Sector Composition
| 1 | Technology | 36.63% |
| 2 | Healthcare | 15.9% |
| 3 | Consumer Discretionary | 10.83% |
| 4 | Financials | 10.24% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Liberty Media Series A
FWONA
$22.5B
| $91.9M | 0.05% |
967,291
+5,050
| +0.5% | +$480K |
|
277
IBM
IBM
$230B
| $91.5M | 0.04% |
310,399
+180,012
| +138% | +$53.1M |
|
278
iShares Core S&P 500 ETF
IVV
$662B
| $91M | 0.04% |
146,497
-90,362
| -38% | -$56.1M |
|
279
monday.com
MNDY
$9.33B
| $90.8M | 0.04% |
288,687
+174,043
| +152% | +$54.7M |
|
280
HDFC Bank
HDB
$180B
| $90.5M | 0.04% |
1,180,927
+253,080
| +27% | +$19.4M |
|
281
Dyne Therapeutics
DYN
$1.87B
| $89.9M | 0.04% |
9,437,962
-915,454
| -9% | -$8.72M |
|
282
Trip.com Group
TCOM
$46.8B
| $89.5M | 0.04% |
1,525,592
-831,491
| -35% | -$48.8M |
|
283
Berkshire Hathaway Class B
BRK.B
$1.09T
| $89.3M | 0.04% |
184,102
-4,049
| -2% | -$1.96M |
|
284
HealthEquity
HQY
$8.42B
| $89.3M | 0.04% |
852,595
+7,556
| +0.9% | +$792K |
|
285
Rhythm Pharmaceuticals
RYTM
$6.85B
| $89.3M | 0.04% |
1,411,902
-243,448
| -15% | -$15.4M |
|
286
Edwards Lifesciences
EW
$47.7B
| $89M | 0.04% |
1,137,366
+134,865
| +13% | +$10.5M |
|
287
Roper Technologies
ROP
$56.6B
| $88.7M | 0.04% |
156,536
+6,990
| +5% | +$3.96M |
|
288
Silgan Holdings
SLGN
$4.78B
| $87.3M | 0.04% |
1,611,715
+40,849
| +3% | +$2.21M |
|
289
Welltower
WELL
$112B
| $87.3M | 0.04% |
568,222
-42,280
| -7% | -$6.5M |
|
290
Scholar Rock
SRRK
$3.1B
| $86.7M | 0.04% |
2,450,286
+780,099
| +47% | +$27.6M |
|
291
Teva Pharmaceuticals
TEVA
$21.3B
| $86.6M | 0.04% |
5,164,890
-913,351
| -15% | -$15.3M |
|
|
CNTA
292
Centessa Pharmaceuticals
CNTA
$2.12B
| $85.8M | 0.04% |
6,532,768
+610,282
| +10% | +$8.02M |
|
293
Kirby Corp
KEX
$4.98B
| $85.4M | 0.04% |
753,078
+60,393
| +9% | +$6.85M |
|
294
iShares Core International Aggregate Bond Fund
IAGG
$10.9B
| $83.6M | 0.04% |
1,635,834
-14,853
| -0.9% | -$759K |
|
295
McDonald's
MCD
$227B
| $83.5M | 0.04% |
285,720
-674,029
| -70% | -$197M |
|
296
Nova
NVMI
$7.29B
| $83.2M | 0.04% |
302,411
+78,698
| +35% | +$21.7M |
|
297
Inspire Medical Systems
INSP
$2.56B
| $83.2M | 0.04% |
640,923
-1,837
| -0.3% | -$238K |
|
298
Itron
ITRI
$5.51B
| $83M | 0.04% |
630,305
+81,024
| +15% | +$10.7M |
|
299
Wintrust Financial
WTFC
$9.19B
| $82.4M | 0.04% |
664,240
+11,510
| +2% | +$1.43M |
|
300
Disc Medicine
IRON
$2.09B
| $82.3M | 0.04% |
1,553,961
+130,702
| +9% | +$6.92M |
|